Duquesne Family Office »

Tg Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.3M 280k 15.21